Given the prevalence of fibrosis in chronic liver diseases, numerous therapeutic approaches for managing liver disease prioritize addressing and potentially reversing fibrosis to varying degrees. However, the lack of preclinical research tools for studying liver disease has hindered advancements in therapeutic development, despite the pressing need for effective treatments and the absence of a cure for liver fibrosis.
Learn how researchers used shear wave elastography on the Vega® automated high-throughput ultrasound system to non-invasively assess liver fibrosis and steatosis in response to therapeutic interventions in two NASH mouse models.
For research use only. Not for use in diagnostic procedures.
Temporal tracking of an effective intervention in rodent liver fibrosis